🇺🇸 FDA
Patent

US 7722898

Modified-release preparations containing oxcarbazepine and derivatives thereof

granted A61KA61K2800/56A61K31/55

Quick answer

US patent 7722898 (Modified-release preparations containing oxcarbazepine and derivatives thereof) held by Supernus Pharmaceuticals, Inc. expires Mon May 20 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Supernus Pharmaceuticals, Inc.
Grant date
Tue May 25 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 20 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K2800/56, A61K31/55, A61K9/0073, A61K9/2013